1. Home
  2. MNKD vs APLD Comparison

MNKD vs APLD Comparison

Compare MNKD & APLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • APLD
  • Stock Information
  • Founded
  • MNKD 1991
  • APLD 2001
  • Country
  • MNKD United States
  • APLD United States
  • Employees
  • MNKD N/A
  • APLD N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • APLD Investment Bankers/Brokers/Service
  • Sector
  • MNKD Health Care
  • APLD Finance
  • Exchange
  • MNKD Nasdaq
  • APLD Nasdaq
  • Market Cap
  • MNKD 1.9B
  • APLD 1.6B
  • IPO Year
  • MNKD 2004
  • APLD N/A
  • Fundamental
  • Price
  • MNKD $6.01
  • APLD $8.90
  • Analyst Decision
  • MNKD Buy
  • APLD Strong Buy
  • Analyst Count
  • MNKD 6
  • APLD 8
  • Target Price
  • MNKD $8.92
  • APLD $11.88
  • AVG Volume (30 Days)
  • MNKD 2.7M
  • APLD 20.8M
  • Earning Date
  • MNKD 02-25-2025
  • APLD 01-14-2025
  • Dividend Yield
  • MNKD N/A
  • APLD N/A
  • EPS Growth
  • MNKD N/A
  • APLD N/A
  • EPS
  • MNKD 0.08
  • APLD N/A
  • Revenue
  • MNKD $267,200,000.00
  • APLD $211,620,000.00
  • Revenue This Year
  • MNKD $45.45
  • APLD $64.99
  • Revenue Next Year
  • MNKD $16.45
  • APLD $55.02
  • P/E Ratio
  • MNKD $75.81
  • APLD N/A
  • Revenue Growth
  • MNKD 51.35
  • APLD 84.57
  • 52 Week Low
  • MNKD $3.17
  • APLD $2.36
  • 52 Week High
  • MNKD $7.63
  • APLD $11.25
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 37.75
  • APLD 51.72
  • Support Level
  • MNKD $5.98
  • APLD $8.11
  • Resistance Level
  • MNKD $6.32
  • APLD $9.73
  • Average True Range (ATR)
  • MNKD 0.21
  • APLD 0.88
  • MACD
  • MNKD -0.04
  • APLD 0.02
  • Stochastic Oscillator
  • MNKD 20.55
  • APLD 53.41

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About APLD Applied Digital Corporation

Applied Digital Corp is a designer, developer, and operator of next-generation digital infrastructure across North America. It provides digital infrastructure solutions and cloud services to industries like High-Performance Computing (HPC) and Artificial Intelligence (AI). The company operates in the following business segments; Data Center Hosting Business, Cloud Services Business, and HPC Hosting Business. The majority of its revenue is generated from the Data Center Hosting Business which operates data centers to provide energized space to crypto mining customers.

Share on Social Networks: